FDA 483 - MEDTRONIC GRAND RAPIDS - December 15, 2025
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Medtronic Grand Rapids, a medical device manufacturer, revealed significant deficiencies in environmental control procedures and the corrective and preventive action (CAPA) system. Observations included an unqualified clean room with an out-of-specification air change rate, inadequate and incomplete risk assessments for clean rooms, and improper personnel gowning and hygiene practices. Furthermore, the firm failed to escalate microbiological nonconformances into CAPAs and did not adequately document periodic reviews of environmental monitoring data.
ID · cd69304f-4b6c-46f7-8e02-7cced9a27023